Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amgen
(NQ:
AMGN
)
347.94
-5.34 (-1.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,603,585
Open
352.72
Bid (Size)
345.88 (80)
Ask (Size)
349.04 (80)
Prev. Close
353.28
Today's Range
345.87 - 354.16
52wk Range
261.43 - 391.29
Shares Outstanding
538,800,000
Dividend Yield
2.90%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Roivant and Immunovant Solidify Market Leadership as Brepocitinib and FcRn Programs Hit Critical Clinical Milestones
Today 17:27 EDT
The biotechnology sector witnessed a seismic shift this week as Roivant Sciences (Nasdaq: ROIV) and its subsidiary Immunovant (Nasdaq: IMVT) reported a series of clinical and regulatory updates that...
Via
MarketMinute
Topics
Intellectual Property
Dow, S&P 500, Nasdaq: From Morning Meltdown to Midday "Meh"
↗
Today 14:45 EDT
Markets opened lower on Iran fears and a Tesla stumble, but bounced back. Here's what investors need to know about Thursday's volatile session.
Via
The Motley Fool
Topics
Government
Stocks
World Trade
Performance
YTD
+6.2%
+6.2%
1 Month
-9.8%
-9.8%
3 Month
+6.3%
+6.3%
6 Month
+16.6%
+16.6%
1 Year
+13.4%
+13.4%
More News
Read More
The Trillion-Dollar Treatment: A Deep Dive into Eli Lilly and Company (LLY)
Today 9:41 EDT
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
Gilead Sciences Acquires Ouro Medicines for $2.2 Billion to Lead 'Immune Reset' Revolution
March 31, 2026
Via
MarketMinute
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks
↗
March 30, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
Institutional Titans Bet Big on Amgen as Dividend Yield Hits 2.9% Benchmark
March 23, 2026
Via
MarketMinute
Topics
ETFs
Earnings
FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market
March 23, 2026
Via
MarketMinute
Anthropic Is Worth $380 Billion: This Little-Known ETF Could Let You Own a Piece Before It IPOs
↗
March 19, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown
March 18, 2026
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report
↗
March 16, 2026
Via
Benzinga
1 ETF That Could Turn $100 Per Month Into $67,380
↗
March 15, 2026
Via
The Motley Fool
Topics
ETFs
Economy
World Trade
2 Mega-Cap Stocks to Keep an Eye On and 1 Facing Headwinds
March 13, 2026
Via
StockStory
Topics
Energy
Rapid Micro (RPID) Earnings Call Transcript
↗
March 12, 2026
Via
The Motley Fool
Topics
Earnings
Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
March 08, 2026
Via
StockStory
Topics
Artificial Intelligence
Better Weight Loss Stock: Novo Nordisk Vs. Amgen
↗
March 08, 2026
Via
The Motley Fool
IBRX Stock Extends Rally To Day 3: Founder Drops ‘Prelude’ To 2025 Earnings, Slams Bristol Myers, Amgen Cancer Playbook
↗
March 03, 2026
Via
Stocktwits
Topics
Artificial Intelligence
2 Profitable Stocks with Solid Fundamentals and 1 Facing Headwinds
March 02, 2026
Via
StockStory
A Couple's Financial Manifesto, Revisited
↗
March 02, 2026
Via
The Motley Fool
Topics
Stocks
The Valuation Reset: A Deep-Dive into Novo Nordisk (NVO) in 2026
February 27, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Novo Nordisk Shares Tumble 15.1% After CagriSema Fails to Topple Eli Lilly in Head-to-Head Trial
February 23, 2026
Via
MarketMinute
Eli Lilly Surges as Novo Nordisk’s "CagriSema" Stumbles in High-Stakes Obesity Head-to-Head
February 23, 2026
Via
MarketMinute
Novo Nordisk Shares Plunge 13% as Next-Gen Weight Loss Drug CagriSema Fails to Topple Eli Lilly in Landmark Trial
February 23, 2026
Via
MarketMinute
Topics
Earnings
1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down
February 22, 2026
Via
StockStory
1 Momentum Stock to Research Further and 2 We Avoid
February 18, 2026
Via
StockStory
The Trillion-Dollar Pharmaceutical Giant: Eli Lilly Makes History as Weight-Loss Revolution Drives Unprecedented Growth
February 17, 2026
Via
MarketMinute
Topics
Earnings
Economy
Frequently Asked Questions
Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 347.94
When was Amgen last traded?
The last trade of Amgen was at 04/02/26 04:00 PM ET
What is the market capitalization of Amgen?
The market capitalization of Amgen is 187.47B
How many shares of Amgen are outstanding?
Amgen has 187B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.